These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 18329532)

  • 1. Vascular disease in scleroderma: mechanisms of vascular injury.
    Kahaleh B
    Rheum Dis Clin North Am; 2008 Feb; 34(1):57-71; vi. PubMed ID: 18329532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The microvascular endothelium in scleroderma.
    Kahaleh B
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v14-5. PubMed ID: 18784128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular complications of scleroderma.
    Guiducci S; Giacomelli R; Cerinic MM
    Autoimmun Rev; 2007 Sep; 6(8):520-3. PubMed ID: 17854742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular involvement in systemic sclerosis (SSc).
    Kahaleh MB
    Clin Exp Rheumatol; 2004; 22(3 Suppl 33):S19-23. PubMed ID: 15344592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular disease in scleroderma. Endothelial T lymphocyte-fibroblast interactions.
    Kahaleh MB
    Rheum Dis Clin North Am; 1990 Feb; 16(1):53-73. PubMed ID: 2406811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive investigation of disease-specific short peptides in sera from patients with systemic sclerosis: complement C3f-des-arginine, detected predominantly in systemic sclerosis sera, enhances proliferation of vascular endothelial cells.
    Xiang Y; Matsui T; Matsuo K; Shimada K; Tohma S; Nakamura H; Masuko K; Yudoh K; Nishioka K; Kato T
    Arthritis Rheum; 2007 Jun; 56(6):2018-30. PubMed ID: 17530642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions.
    Avouac J; Wipff J; Goldman O; Ruiz B; Couraud PO; Chiocchia G; Kahan A; Boileau C; Uzan G; Allanore Y
    Arthritis Rheum; 2008 Nov; 58(11):3550-61. PubMed ID: 18975312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic sclerosis. A vascular perspective.
    LeRoy EC
    Rheum Dis Clin North Am; 1996 Nov; 22(4):675-94. PubMed ID: 8923590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do infections facilitate the emergence of systemic sclerosis?
    Grossman C; Dovrish Z; Shoenfeld Y; Amital H
    Autoimmun Rev; 2011 Mar; 10(5):244-7. PubMed ID: 20863912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial injury in the initiation and progression of vascular disorders.
    Tesfamariam B; DeFelice AF
    Vascul Pharmacol; 2007 Apr; 46(4):229-37. PubMed ID: 17218160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blunted increase of digital skin vasomotion following acetylcholine and sodium nitroprusside iontophoresis in systemic sclerosis patients.
    Rossi M; Bazzichi L; Di Maria C; Franzoni F; Raimo K; Della Rossa A; Santoro G; Bombardieri S
    Rheumatology (Oxford); 2008 Jul; 47(7):1012-7. PubMed ID: 18430760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial cell activation in models of vascular and glomerular injury.
    Stewart RJ; Marsden PA
    Kidney Int Suppl; 1994 Feb; 45():S37-44. PubMed ID: 8158895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral arterial stiffness and endothelial dysfunction in idiopathic and scleroderma associated pulmonary arterial hypertension.
    Peled N; Shitrit D; Fox BD; Shlomi D; Amital A; Bendayan D; Kramer MR
    J Rheumatol; 2009 May; 36(5):970-5. PubMed ID: 19369472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathology of scleroderma vascular disease.
    Fleming JN; Schwartz SM
    Rheum Dis Clin North Am; 2008 Feb; 34(1):41-55; vi. PubMed ID: 18329531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis.
    Andreucci E; Margheri F; Peppicelli S; Bianchini F; Ruzzolini J; Laurenzana A; Fibbi G; Bruni C; Bellando-Randone S; Guiducci S; Romano E; Manetti M; Matucci-Cerinic M; Calorini L
    Rheumatology (Oxford); 2021 Oct; 60(10):4508-4519. PubMed ID: 33471123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial dysfunction in systemic sclerosis.
    Altorok N; Wang Y; Kahaleh B
    Curr Opin Rheumatol; 2014 Nov; 26(6):615-20. PubMed ID: 25191994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of vascular damage in SSc--implications for vascular treatment strategies.
    Guiducci S; Distler O; Distler JH; Matucci-Cerinic M
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v18-20. PubMed ID: 18784130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased arterial stiffness as the marker of vascular involvement in systemic sclerosis.
    Timár O; Soltész P; Szamosi S; Dér H; Szántó S; Szekanecz Z; Szücs G
    J Rheumatol; 2008 Jul; 35(7):1329-33. PubMed ID: 18484693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Large vessels vasculopathy in systemic sclerosis].
    Tejera Segura B; Ferraz-Amaro I
    Med Clin (Barc); 2015 Dec; 145(11):488-92. PubMed ID: 25726305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular disease in scleroderma: angiogenesis and vascular repair.
    Mulligan-Kehoe MJ; Simons M
    Rheum Dis Clin North Am; 2008 Feb; 34(1):73-9; vi. PubMed ID: 18329533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.